Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ragde

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Reduction of radioactive seed embolization to the lung following prostate brachytherapyE M Tapen, J C Blasko, P D Grimm, et al.
Seminars in Surgical Oncology|November 14, 1997
Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-upH Ragde, J C Blasko, P D Grimm, et al.
Anticancer Research|July 1, 1995
Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patientsG Murphy, H Ragde, G Kenny, et al.
The Prostate|May 27, 1999
GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trialS J Simmons, B A Tjoa, M Rogers, et al.
The Prostate|July 1, 1999
Follow-up evaluation of a phase II prostate cancer vaccine trialB A Tjoa, S J Simmons, A Elgamal, et al.
The Prostate|August 4, 1998
Method for identifying prostate cells in semen using flow cytometryR J Barren, E H Holmes, A L Boynton, et al.
The Prostate|September 1, 1997
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptidesB A Tjoa, S J Erickson, V A Bowes, et al.
The Prostate|April 30, 1999
Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatmentG P Murphy, B A Tjoa, S J Simmons, et al.
The Prostate|May 6, 1998
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)M L Salgaller, P A Lodge, J G McLean, et al.
The Prostate|October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancerG P Murphy, M J Troychak, O E Cobb, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Reduction of radioactive seed embolization to the lung following prostate brachytherapyE M Tapen, J C Blasko, P D Grimm, et al.
Seminars in Surgical Oncology|November 14, 1997
Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-upH Ragde, J C Blasko, P D Grimm, et al.
Anticancer Research|July 1, 1995
Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patientsG Murphy, H Ragde, G Kenny, et al.
The Prostate|May 27, 1999
GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trialS J Simmons, B A Tjoa, M Rogers, et al.
The Prostate|July 1, 1999
Follow-up evaluation of a phase II prostate cancer vaccine trialB A Tjoa, S J Simmons, A Elgamal, et al.
The Prostate|August 4, 1998
Method for identifying prostate cells in semen using flow cytometryR J Barren, E H Holmes, A L Boynton, et al.
The Prostate|September 1, 1997
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptidesB A Tjoa, S J Erickson, V A Bowes, et al.
The Prostate|April 30, 1999
Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatmentG P Murphy, B A Tjoa, S J Simmons, et al.
The Prostate|May 6, 1998
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)M L Salgaller, P A Lodge, J G McLean, et al.
The Prostate|October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancerG P Murphy, M J Troychak, O E Cobb, et al.
Pageof 5